- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04010851
The Effects of a Peer Co-led Educational Programme for Parents of Children With ADHD (ADHD)
The Effects of a Peer Co-led Educational Programme for Parents of Children With ADHD: A Feasibility Randomized Controlled Trial
Study Overview
Status
Intervention / Treatment
Detailed Description
The primary objective of this trial is to evaluate the acceptability and feasibility of the intervention, to assure that procedures are adequate for a subsequent full size randomized controlled trial (RCT), and to determine the likely size of the trial comparing an ADHD specific parenting peer co-led intervention for parents of children with ADHD symptoms.
Specific objectives are:
(I) investigate whether parents of children recently diagnosed with ADHD are willing to be randomized to the intervention, (II) whether sufficient numbers of families can be recruited and retained such that a full-scale RCT is likely to be feasible, (III) whether research procedures and efficacy measures are feasible and acceptable to participating families and the outpatient clinics, and (IV) whether families participating in the intervention are satisfied with the intervention.
This feasibility study is not designed to detect a treatment effect, therefore a maximum of 50 parents will be recruited. The measurements will be taken in the children (at baseline and 3 months) and parents (at baseline, two weeks, pre-post intervention and 3 months follow-up) to determine the feasibility and acceptability. These measures are chosen because they address key components of the intervention (activation, quality of life and psychological well-being). Multiple measures of similar constructs will be administered where possible (e.g., psychological well-being and quality of life) to determine which measure to include in the definitive trial according to feasibility, acceptability, and sensitivity.
Feasibility assessments:
- Feasibility of recruitment.
- Acceptability of randomization and procedures will be determined by measuring loss to follow-up (post-test and 3-month follow-up), and reasons for withdrawal will be used collected.
- Acceptability of the intervention will be determined based on the number of sessions attended by participants in the peer co-led education. We will also reported on satisfaction with the program.
- Feasibility of quantitative measures will be deemed acceptable if no questionnaires are missing in full in more than 25% of the participants and if reliability was higher than 0.70.
- Follow-up response rates (post-intervention and 3 months follow-ups).
Study Type
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Parents of children aged 6 - 12 with a formal diagnosis of ADHD, following a standardised assessment.
Exclusion Criteria:
- Participants already taking part in research on a parenting intervention will also be ineligible to participate.
- Families attending other parenting groups
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Peer co-led educational group
The intervention delivered in a group format is added to treatment as usual.
After the parents participate in the one day-intervention, they can continue in self-help groups, which meet once a week for a 2-hour evening session.
User representatives lead these weekly self-help groups, which do not require user-fees and aim to offer practical tools, support and information to increase the parent's skills, knowledge and confidence.
|
The intervention is delivered in a group format, which takes the form of a full day's training, focusing on ADHD diagnosis, its treatment, how to cope with the challenges related to living with ADHD, as well as coping with challenges of parenting a child with chronic health conditions.
After this one day-intervention, the participants can continue in self-help groups, which meet once a week for a 2-hour evening session.
User representatives lead these weekly self-help groups, which do not require user-fees and aim to offer practical tools, support and information to increase the parent's skills, knowledge and confidence.
Participants are encouraged to adopt an active role in order to achieve a positive parent/provider partnership.
|
Other: Control group
The control goup will receive treatment as usual.
|
Control group will receive treatment as usual, including different treatment options that can help alleviate the symptoms of ADHD and arm families with the tools needed to better handle problem behaviors when they arise.
These interventions include: medication, psychotherapy, or a combination of these two approaches.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Feasibility of recruitment
Time Frame: Over a two year study period
|
Feasibility of recruitment will be assessed by determining the recruitment rate, by monitoring patient screening and subsequent agreement to participate.
|
Over a two year study period
|
Satisfaction with the intervention
Time Frame: From baseline to 12- and 52-weeks follow-up
|
Parent satisfaction will be measured by means of the client satisfaction Questionnaire, CSQ-3 as it applies to the group-based educational programme.
The scale comprises three items measured on a scale from 1 (not satisfied) to 4 (very satisfied).
|
From baseline to 12- and 52-weeks follow-up
|
Parental activation
Time Frame: From baseline to 12- and 52-weeks follow-up
|
Parental activation will be measure with the P-PAM-13.
The 13-items P-PAM has four possible response options ranging from (1) strongly disagree, to (4) strongly agree, and an additional 'not applicable' option.
|
From baseline to 12- and 52-weeks follow-up
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Parental well-being
Time Frame: From baseline to 12- and 52-weeks follow-up
|
Parental well-being will be measured by the WHO-5 Well-being Index.
The questionnaire has five items rated on a six-point scale from 0 (all the time) to 5 (at no time); this items are transformed into 0-100 scales (high scores indicate a better well-being).
|
From baseline to 12- and 52-weeks follow-up
|
Parental quality of life
Time Frame: From baseline to 12- and 52-weeks follow-up
|
Parental quality of life will be measured by the 10- items Multicultural Quality of Life Index (MQLI) which cover key aspects of the concept, from physical well-being to spiritual fulfilment.
The MQLI questionnaire has ten items.
|
From baseline to 12- and 52-weeks follow-up
|
Shared decision making
Time Frame: From baseline to 12- and 52-weeks follow-up
|
It will be assessed using a modified version of the Control Preferences Scale to provide information about the parent's preferred role in involvement.
|
From baseline to 12- and 52-weeks follow-up
|
Parental involvement in treatment decision
Time Frame: From baseline to 12- and 52-weeks follow-up
|
Parent involvement will be assessed using a modified version of the CollaboRATE scale
|
From baseline to 12- and 52-weeks follow-up
|
Beliefs about medicines
Time Frame: From baseline to 12- and 52-weeks follow-up
|
To investigate the beliefs about medicines we will use the Beliefs about Medicines Questionnaire (BMQ).
|
From baseline to 12- and 52-weeks follow-up
|
Adherence
Time Frame: From baseline to 12- and 52-weeks follow-up
|
To investigate medication adherence using the Medication Adherence Rating Scale 5 items.
|
From baseline to 12- and 52-weeks follow-up
|
ADHD Scale Parent Version
Time Frame: From baseline to 12- and 52-weeks follow-up
|
The SNAP-IV 18-Item will be use to evaluate ADHD, the SNAP-IV 18-Item Scale Parent Version is an abbreviated version of the Swanson, Nolan, and Pelham (SNAP).
The questionnaire includes items for the two subsets of symptoms, inattention (items 1-9) and hyperactivity/impulsivity (items 10-18), from the DSM-IV criteria for ADHD.
The scores in each of the two subsets are added together.
SNAP-IV is used to measure ADHD symptoms and behavioral problems in school-aged children.
Symptom severity is rated on a 4-point scale.
|
From baseline to 12- and 52-weeks follow-up
|
Level of functioning of children in Child
Time Frame: From baseline to 12- and 52-weeks follow-up
|
The C-GAS will be used to assess the overall level of functioning of children.
The C-GAS is a numeric scale ranging from 1 to 100 used to assess the overall level of functioning of children in Child and Adolescent Mental Health Services, with high scores indicating better functioning.
|
From baseline to 12- and 52-weeks follow-up
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Participation in treatment
Time Frame: From baseline to 12- and 54-weeks follow-up.
|
Information regarding treatment participation and use of services will be collected via Patient Administrative System (PAS).
|
From baseline to 12- and 54-weeks follow-up.
|
Collaborators and Investigators
Investigators
- Principal Investigator: Ingunn P. Mundal, PhD, Molde University College
- Principal Investigator: Mariela Loreto Lara Cabrera, PhD, St Olavs Hospital, Department of research and development AFFU, and NTNU
- Study Director: Rolf W. Gråwe, Phd prof, Norwegian University of Science and Technology
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Anticipated)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2018/1196/REK Mid Norway
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Attention Deficit Disorder With Hyperactivity
-
Ornit CohenUnknownAttention Deficit Hyperactivity Disorder | Attention Deficit Disorder With Hyperactivity | Attention Deficit Disorder | Attention Deficit Disorders With Hyperactivity | Attention Deficit Hyperactivity DisordersIsrael
-
Cingulate TherapeuticsRecruitingPhase 3 Efficacy and Safety Laboratory Classroom Study in Pediatrics (6-12) With ADHD Using CTx-1301ADHD | Attention Deficit Hyperactivity Disorder | Attention Deficit Disorder With Hyperactivity | ADHD - Combined Type | Attention Deficit Hyperactivity Disorder Combined | Attention Deficit Hyper Activity | Attention-deficit HyperactivityUnited States
-
Karolinska InstitutetCompletedAttention Deficit Disorder With Hyperactivity (ADHD)Sweden
-
Rabin Medical CenterNG Solutions LtdRecruitingADHD - Attention Deficit Disorder With HyperactivityIsrael
-
Fondation LenvalCompletedAttention Deficit Disorder With Hyperactivity | Attention Deficit Disorder Without HyperactivityFrance
-
Clinical and Translational Genome Research Institute...Children's Specialized HospitalTerminatedAttention Deficit Disorders With HyperactivityUnited States
-
University of PennsylvaniaCompletedAttention Deficit Disorder With Hyperactivity (ADHD)United States
-
Nemours Children's ClinicCompletedAttention Deficit Hyperactivity Disorder | Attention Deficit Disorder With Hyperactivity | Attention Deficit DisorderUnited States
-
Massachusetts General HospitalRecruitingAttention Deficit Disorder With Hyperactivity | Attention Deficit DisorderUnited States
-
New River PharmaceuticalsShireCompletedAttention Deficit Hyperactivity Disorder | Attention Deficit Disorders With Hyperactivity | Attention Deficit Hyperactivity DisordersUnited States
Clinical Trials on Peer co-led educational group
-
University of MichiganBlue Cross Blue Shield of Michigan FoundationCompleted
-
Chinese University of Hong KongTaipei Medical University; Hospital Authority, Hong Kong; Jilin University Medical...Active, not recruiting
-
Stanford UniversityActive, not recruitingEating DisordersUnited States
-
Stanford UniversityCompleted
-
Children's Hospital Medical Center, CincinnatiCompleted
-
Oregon Research InstituteCompletedEating Disorder PreventionUnited States
-
Washington University School of MedicineNational Institute of Mental Health (NIMH)Completed
-
Radboud University Medical CenterThe health Care Insurance Board (CVZ); Department of Preventive and Restorative...Completed
-
University of PittsburghUniversity of Pittsburgh Medical CenterTerminatedAdolescent Behavior | E-Cig UseUnited States
-
US Department of Veterans AffairsCompleted